A Phase Ib/II Clinical Study of GH21 Capsules Combined With Osimertinib Mesylate Tablets in Patients With NSCLC

Key facts

Sponsor

Suzhou Genhouse Bio Co., Ltd.

Principal Investigator

Caicun Zhou, Doctorate

（86）021-65115006

Intervention

GH21(drug)

Enrollment

94 enrolled

Eligibility

18 years · All sexes

Timeline

2024 – 2026

Study locations (6)

• The Second Hospital of Anhui Medical University, Hefei, Anhui, China
• The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
• Hunan Cancer Hospital, Changsha, Hunan, China
• Nanjing Drum Tower Hospital, Nanjing, Jiangsu, China
• Shanghai Pulmonary Hospital, Shanghai, Shanghai Municipality, China
• Taizhou Hospital of Zhejiang Province, Linhai, Zhejiang, China

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Catastrophic antiphospholipid syndrome

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE3NCT07458984
  FMT Capsules for rCDI
  Helsinki University Central Hospital
• RECRUITINGPHASE1NCT07297199
  A Study to Learn How the Body Processes BIIB141 (Omaveloxolone) When Taken as a Capsule or as a Tablet Dissolved in Liquid, and to Learn About Its Safety in Healthy Adults Ages 18 to 55
  Biogen
• RECRUITINGPHASE3NCT07165951
  Clinical Trial Comparing TQB2868 Injection Combined With Anlotinib Hydrochloride Capsules With Placebo Combined With Chemotherapy as First-line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)
  Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
• RECRUITINGNANCT07561333
  Comparing ACB+IPACK and ACB+BiFeS Block Combinations for Analgesia in Total Knee Arthroplasty
  Hitit University
• RECRUITINGPHASE2, PHASE3NCT06841679
  Utidelone Capsule Combined With Fluoropyrimidine- and Platinum-containing Therapy in First-line Treatment of Patients With Gastric or Gastroesophageal Junction Adenocarcinoma
  Beijing Biostar Pharmaceuticals Co., Ltd.
• RECRUITINGPHASE1NCT07044271
  A Study of Multiple Olomorasib (LY3537982) Capsules in Healthy Participants
  Eli Lilly and Company
• RECRUITINGPHASE1NCT06943677
  A Clinical Trial on the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TQB3019 Capsule in Subjects With Advanced Malignant Tumors
  Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
• RECRUITINGPHASE2NCT06822946
  Zhibitai Capsules for the Treatment of Primary Hyperlipidemia
  Chengdu Diao Jiuhong Pharmaceutical Factory

See all trials for Catastrophic antiphospholipid syndrome →